Immunopharmacology of Oral Betalactams

References

• Dammacco F, ed. Immunologia in medicina - Prefazione. Milano, Edi Ermes 1989: VII-IX.
   Google Scholar
• Hauser WE, Remington JS. Effect of antibiotics on the immune response. Am J Med 1982; 72: 711–716.
   PubMed Web of Science ®Google Scholar
• Korzeniowski OM. Effects of antibiotics on the mam-malian immune system. Infect Dis Clin North Am 1989; 3: 469–478.
   PubMedGoogle Scholar
• Van Vlem B, Vanholder R, De Paepe P, Vogelaers D, Ringoir S. Immunomodulating effects of antibiotics: literature review. Infection 1996; 24 (4): 275–291.
   PubMed Web of Science ®Google Scholar
• Rifts RE. Antibiotics as biological response modifiers. J Antimicrob Chemother 1990; 26 ( Suppl C): 31-36.
   Google Scholar
• The Lancet. Antibiotics as biological response modifiers. Lancet 1991; 337: 400–401.
   PubMed Web of Science ®Google Scholar
• Labro MT. Valutazione sperimentale di antibiotici come immunomodulatori. J Chemother 1994; 6 (Suppl 3): 11–15.
   PubMedGoogle Scholar
• Gura T. Chemokines take center stage in inflammatory ills. Science 1996; 272: 954–956.
   PubMed Web of Science ®Google Scholar
• Mosman TR, Sad S. The expanding universe of T-cell subsets: Thl, Th2 and more. Immunol Today 1996; 17 (3): 139–146.
   Google Scholar
• Ohnishi H, Kosozume H, Inaba H, et al. Effects of AC-1370, a new semisynthetic cephalosporin, on phagocyte func-tions. Antimicrob Agents Chemother 1983; 23 (6): 874–880.
   PubMed Web of Science ®Google Scholar
• Ohnishi H, Inaba H, Mochizuki H, Kosuzume H. Mechanism of action of AC-13-70 on phagocyte functions. Antimicrob Agents Chemother 1984; 25 (1): 88–92.
   PubMed Web of Science ®Google Scholar
• Grant M, Raiburn JA, Sutherland R, Harkness RA, Gormley IP, Kowolik MJ. Effect of two antibiotics on human granulocyte activities. J Antimicrob Chemother 1983; 11: 543–554.
   PubMed Web of Science ®Google Scholar
• Labro MT. Immunological evaluation of cefodizime: a unique molecule among cephalosporins. Infection 1992; 20 (Suppl 1): 45–47.
   PubMedGoogle Scholar
• Fietta A, Bersani C, Bartoletti R, Grassi FM, Gialdroni-Grassi G. In vitro ed ex vivo enhancement of nonspecific phagocytosis by cefodizime. Chemotherapy 1988; 34: 430–436.
   PubMed Web of Science ®Google Scholar
• Ueta E, Yoneda K, Yamamoto T, Osaki T. Upregulatory effects of cefpimizole natrium on human leuko-cytes. Int J Immunopharmacol 1992; 14 (5): 877–885.
   PubMed Web of Science ®Google Scholar
• Hahn Von H, Kuhring D, Trautmann M, Diamantstein T. Einflug von cefaclor, doxycyclin und weiteren oralen antibi-otika auf die phagozytose polymophkemiger granulozyten und PHA-induzierte stimulation von blutlyphozyten des menschen. Arzheim Forsch Drug Res 1985; 35: 543–546.
   PubMedGoogle Scholar
• Roche Y, Fay M, Gougerot-Pocidalo M-A. Interleukin-1 production by antibiotic-treated human monocytes. J Antimicrob Chemother 1988; 21: 597–607.
   PubMed Web of Science ®Google Scholar
• Labro MT, Babin-Chevaye C, Hakim J. Effects of cefo-taxime and cefodizime on human granulocyte functions in vitro. J Antimicrob Chemother 1986; 18: 233–237.
   PubMed Web of Science ®Google Scholar
• Labro MT. Cefodizime as a biological response modifi-er: a review of its in-vivo, ex-vivo and in-vitro immunomodu-latory properties. J Antimicrob Chemother 1990; 26 ( Suppl C): 37-47.
   Google Scholar
• Pulverer G. Effects of cefodizime and cefotaxime on cel-lular and humoral immune responses. Infection 1992; 20 (Suppl 1): 41–44.
   Google Scholar
• Periti P, Mazzei T, Mini E, Novelli A, Reali EF. Attualita delle cefalosporine in chemioterapia. E.R.S., Firenze 1988: 3-207.
   Google Scholar
• Dantzing AH, Bergin L. Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2. Biochim Biophys Acta 1990; 1027: 211–217.
   PubMed Web of Science ®Google Scholar
• Labro MT, Amit N, Babin-Chevaye C, Hakim J. Cefodizime (HR 221) potentiation of human neutrophil oxy-gen-independent bactericidal activity. J Antimicrob Chemother 1987; 19: 331–341.
   PubMed Web of Science ®Google Scholar
• Kwhller J, Brom J, Schonfeld W, König W. In-vitro enhancement of leucotriene B4 receptor expression on human neutrophils by cefadroxil. J Antimicrob Chemother 1990; 25: 613-520.
   Google Scholar
• Scheffer J, Knoller J, Cullmann W, König W. Effects of cefaclor, cefetamet and Ro 40-6890 on inflammatory responses of human granulocytes. J Antimicrob Chemother 1992; 30: 57–66.
   PubMed Web of Science ®Google Scholar
• Scheffer J, König W. Cephalosporins and inflammatory host reactions. Respiratorion 1993; 60 (Suppl 1): 25–31.
   PubMed Web of Science ®Google Scholar
• Root RK, Comen MS. The microbicidal mechanism of human neutrophils and eosinophils. Rev Infect Dis 1981; 3: 565–568.
   PubMedGoogle Scholar
• Ono Y, Kunii O, Ohyatsu I, et al. Comparative study of the effects of cefodizime and HBW 538 in potentiating the production of reactive oxygen species by human polymorpho-nuclear leukocytes. Chemotherapy 1994; 40: 404–411.
   PubMed Web of Science ®Google Scholar
• Elsbach P, Weiss J. Oxygen-dependent and oxygen-independet mechanisms of microbicidal activity of neutrophils. Immunol Lett 1985; 11: 159–163.
   PubMed Web of Science ®Google Scholar
• Babior BM. Oxygen-dependent microbial killing by phagocytes. N Engl J Med 1978; 298: 659–668.
   PubMed Web of Science ®Google Scholar
• Periti P. Rational choice of an oral beta-lactam antibiot-ic. J Chemother 1997; 9 (Suppl 4): 1–24.
   PubMedGoogle Scholar
• Novelli A, Mazzei T, Cassetta MI, Fallani S, Corti S. Synergism between antimicrobial agents and human polymor-phonuclear leukocytes in vitro. In press 1998.
   Google Scholar
• Horn LH, Opal SM, Lomastro E. Antibiotics, cytokines, and endotoxin: a complex and evolving relationship in Gram-negative sepsis. Scand J Infect Dis 1996; Suppl 101: 9-13.
   Google Scholar
• Kirikae T, Nakano M, Morrison DC. Review - Antibiotic-infuced endotoxin release from bacteria and its clini-cal significance. Microbiol Immunol 1997; 41 (4): 285–294
   PubMed Web of Science ®Google Scholar
• Gould IM, MacKenzie FM. The response of enterobac-teriaceae to I3-lactam antibiotics-'round forms, filaments and the root of all evil'. J Antimicrob Chemother 1997; 40: 495–499.
   PubMed Web of Science ®Google Scholar
• Greenwood D. Antibiotic effects in vitro and the prediciton of clinical response. J Antimicrob Chemother 1997; 40: 499–501.
   PubMed Web of Science ®Google Scholar
• Thornsberry C. Cefaclor AF: correlation of microbiolo-gy and clinical outcome. Postgrad Med J 1992; 68 (Suppl 3): S10–S16.
   PubMedGoogle Scholar
• Periti P. The chemotherapeutic formula revisited - Conclusions. J Chemother 1997; 9 (Suppl 1): 123–132.
   PubMedGoogle Scholar
• Mouton Y, Dubreuil L. In vitro antibiotic testing and its relationship to clinical activity. J Chemother 1997; 9 (Suppl 1): 93–99.
   PubMedGoogle Scholar